Matches in Wikidata for { <http://www.wikidata.org/entity/Q58579561> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- Q58579561 description "2019 թվականին հրատարակված գիտական հոդված" @default.
- Q58579561 description "article scientifique (publié 2019)" @default.
- Q58579561 description "articolo scientifico (pubblicato il 2019)" @default.
- Q58579561 description "artigo científico (publicado na 2019)" @default.
- Q58579561 description "artikull shkencor i botuar më 01 janar 2019" @default.
- Q58579561 description "artículo científico publicado en 2019" @default.
- Q58579561 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q58579561 description "im Jahr 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58579561 description "scientific article published on 01 January 2019" @default.
- Q58579561 description "wetenschappelijk artikel" @default.
- Q58579561 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q58579561 description "научна статия" @default.
- Q58579561 name "Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)" @default.
- Q58579561 name "Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)" @default.
- Q58579561 name "Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)" @default.
- Q58579561 type Item @default.
- Q58579561 label "Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)" @default.
- Q58579561 label "Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)" @default.
- Q58579561 label "Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)" @default.
- Q58579561 prefLabel "Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)" @default.
- Q58579561 prefLabel "Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)" @default.
- Q58579561 prefLabel "Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)" @default.
- Q58579561 P1433 Q58579561-0A439A36-0112-4098-8A2A-23193E24D5B9 @default.
- Q58579561 P1476 Q58579561-C3888ABF-7614-4B7A-ABBA-9C40B5CA051E @default.
- Q58579561 P2093 Q58579561-0DA0C38F-950C-4090-97B0-A795654B04E7 @default.
- Q58579561 P2093 Q58579561-1225ED2C-CFFD-441A-85F0-82059A9EF549 @default.
- Q58579561 P2093 Q58579561-1F84930E-01B1-4946-9FE2-6D425B2C0021 @default.
- Q58579561 P2093 Q58579561-2007B28C-6CC5-4A0B-B1CC-7E31332CAFAE @default.
- Q58579561 P2093 Q58579561-667D2E64-54E6-40D7-8692-AAC975850D7F @default.
- Q58579561 P2093 Q58579561-6B3B5D60-841E-47E5-A9B8-769A1AB5BEF4 @default.
- Q58579561 P2093 Q58579561-A5B322C6-D31D-49E3-8987-05CC35273C40 @default.
- Q58579561 P2093 Q58579561-B58A7CBE-819B-42A7-B68F-373F441B156F @default.
- Q58579561 P275 Q58579561-a2a4e625-b237-4ccc-a237-b06d36de4a39 @default.
- Q58579561 P304 Q58579561-BFB3A230-43F0-4D03-9157-127F06B25F0C @default.
- Q58579561 P31 Q58579561-451CD82D-C9D2-4D87-93FC-F4765629B8D9 @default.
- Q58579561 P31 Q58579561-EA35C452-3A25-4438-9F62-848261C86A16 @default.
- Q58579561 P356 Q58579561-074AC06C-107C-46CC-8C01-921EB39340D1 @default.
- Q58579561 P407 Q58579561-2E50981C-C236-4210-9D0A-973CD32FEC32 @default.
- Q58579561 P433 Q58579561-4DC02994-6180-4C9C-AC49-8C4F9AF18FA8 @default.
- Q58579561 P478 Q58579561-1E85AB78-CA03-45D9-B698-C3D19A660CCE @default.
- Q58579561 P577 Q58579561-A4D18CD6-0587-463E-916B-7ABD056AEC4D @default.
- Q58579561 P6216 Q58579561-81290665-f564-4030-864b-57e2f873fec0 @default.
- Q58579561 P698 Q58579561-A7A0DAF1-87D2-445E-B0CE-45CCA50ABAAC @default.
- Q58579561 P921 Q58579561-1596958D-3F82-48D5-A0DB-6317E5FBEF91 @default.
- Q58579561 P921 Q58579561-3B2B5BED-FA98-414C-938A-4B4C6B8255C2 @default.
- Q58579561 P932 Q58579561-30EC16EA-BC5A-4D39-B2A8-CECE6C7FE59B @default.
- Q58579561 P356 S10096-018-3410-8 @default.
- Q58579561 P698 30406879 @default.
- Q58579561 P1433 Q15754378 @default.
- Q58579561 P1476 "Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)" @default.
- Q58579561 P2093 "Areti Georgopali" @default.
- Q58579561 P2093 "Emilio Bouza" @default.
- Q58579561 P2093 "Florian Thalhammer" @default.
- Q58579561 P2093 "Graham Wetherill" @default.
- Q58579561 P2093 "Joop van Oene" @default.
- Q58579561 P2093 "Maria J G T Vehreschild" @default.
- Q58579561 P2093 "Simon D Goldenberg" @default.
- Q58579561 P2093 "Surabhi Taori" @default.
- Q58579561 P275 Q20007257 @default.
- Q58579561 P304 "199" @default.
- Q58579561 P31 Q13442814 @default.
- Q58579561 P31 Q1348305 @default.
- Q58579561 P356 "10.1007/S10096-018-3410-8" @default.
- Q58579561 P407 Q1860 @default.
- Q58579561 P433 "1" @default.
- Q58579561 P478 "38" @default.
- Q58579561 P577 "2019-01-01T00:00:00Z" @default.
- Q58579561 P6216 Q50423863 @default.
- Q58579561 P698 "30406879" @default.
- Q58579561 P921 Q310543 @default.
- Q58579561 P921 Q917447 @default.
- Q58579561 P932 "6315086" @default.